Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,847
datasets available to search
ShareScore release 0.9.0
Dataset results
1,847 results for “Psoriasis”
A Study of Ustekinumab to Evaluate a "Subject-tailored" Maintenance Dosing Approach in Subjects With Moderate-to-Severe Plaque Psoriasis
ClinicalTrials.gov study NCT01550744. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )
ClinicalTrials.gov study NCT03047395. IPD Sharing: YES. Countries: 17. Publications: 4.
A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet)
ClinicalTrials.gov study NCT06095102. IPD Sharing: YES. Countries: 11. Publications: 1.
Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects
ClinicalTrials.gov study NCT00658606. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.
ClinicalTrials.gov study NCT02425826. IPD Sharing: YES. Countries: 1. Publications: 3.
Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.
ClinicalTrials.gov study NCT01232283. IPD Sharing: Not stated. Countries: 9. Publications: 2.
Comparison of Indigo Naturalis Oil Extract and Calcipotriol Solution in Treating Psoriasis
ClinicalTrials.gov study NCT01445886. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study in Participants With Moderate to Severe Psoriasis
ClinicalTrials.gov study NCT01107457. IPD Sharing: YES. Countries: 2. Publications: 3.
Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast
ClinicalTrials.gov study NCT03442088. IPD Sharing: NO. Countries: 1. Publications: 45.
Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis
ClinicalTrials.gov study NCT03073200. IPD Sharing: YES. Countries: 13. Publications: 1.
Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT00195676. IPD Sharing: Not stated. Countries: 10. Publications: 2.
A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 306)
ClinicalTrials.gov study NCT02368210. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis
ClinicalTrials.gov study NCT01154101. IPD Sharing: YES. Countries: 1. Publications: 1.
This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is
ClinicalTrials.gov study NCT03635099. IPD Sharing: YES. Countries: 3. Publications: 2.
Tapinarof for the Treatment of Plaque Psoriasis in Adults (3002)
ClinicalTrials.gov study NCT03983980. IPD Sharing: NO. Countries: 2. Publications: 4.
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Repeat Doses of GSK2982772 in Subjects With Psoriasis
ClinicalTrials.gov study NCT02776033. IPD Sharing: YES. Countries: 1. Publications: 1.
A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis
ClinicalTrials.gov study NCT03210961. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study to Test the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic Psoriasis
ClinicalTrials.gov study NCT03051217. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis Naive to Systemic Treatment
ClinicalTrials.gov study NCT02634801. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
ClinicalTrials.gov study NCT03412747. IPD Sharing: YES. Countries: 9. Publications: 9.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.